Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2026)

Cue Biopharma has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $628000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 67.89% year-over-year to $628000.0; the TTM figure through Jun 2026 stood at $628000.0 (down 67.89% YoY), while the FY2025 annual figure was $666000.0, down 65.93% from the prior year.
• Other Non-Current Assets came in at $628000.0 for Q2 2026 at Cue Biopharma, down from $666000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.8 million in Q2 2022 to a low of $628000.0 in Q2 2026.
• Average Other Non-Current Assets over 5 years is $2.4 million, with a median of $2.7 million recorded in 2023.
• Year-over-year, Other Non-Current Assets soared 44.98% in 2022 and slumped 75.2% in 2025.
• Over 5 years, Other Non-Current Assets stood at $3.1 million in 2022, then retreated by 13.67% to $2.7 million in 2023, then declined by 27.32% to $2.0 million in 2024, then plunged by 65.93% to $666000.0 in 2025, then dropped by 5.71% to $628000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $628000.0 in Q2 2026, $666000.0 in Q4 2025, and $667000.0 in Q3 2025.